BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 23752220)

  • 1. Skew of plasma low- and high-density lipoprotein distributions to less dense subfractions in normotriglyceridemic chronic kidney disease patients on maintenance hemodialysis treatment.
    Homma K; Homma Y; Shiina Y; Wakino S; Suzuki M; Fujishima S; Hayashi K; Hori S; Itoh H
    Nephron Clin Pract; 2013; 123(1-2):41-5. PubMed ID: 23752220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia.
    Homma Y; Kobayashi T; Yamaguchi H; Sakane H; Ozawa H; Matsuda M; Mikami Y; Mikami Y; Nakamura H
    Artery; 1993; 20(1):1-18. PubMed ID: 8447724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase.
    Chung BH; Segrest JP; Franklin F
    Atherosclerosis; 1998 Dec; 141(2):209-25. PubMed ID: 9862170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smaller low-density lipoprotein size as a possible risk factor for the prevalence of coronary artery diseases in haemodialysis patients: associations of cholesteryl ester transfer protein and the hepatic lipase gene polymorphism with low-density lipoprotein size.
    Kimura H; Miyazaki R; Imura T; Masunaga S; Shimada A; Mikami D; Kasuno K; Takahashi N; Hirano T; Yoshida H
    Nephrology (Carlton); 2011 Aug; 16(6):558-66. PubMed ID: 21352420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triglyceride-rich lipoproteins in chronic kidney disease patients undergoing maintenance haemodialysis treatment.
    Homma K; Homma Y; Yamaguchi S; Shiina Y; Wakino S; Hayashi K; Hori S; Itoh H
    Int J Clin Pract; 2012 Apr; 66(4):394-8. PubMed ID: 22420498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of hepatic lipase in intermediate-density lipoprotein and small, dense low-density lipoprotein formation in hemodialysis patients.
    Oi K; Hirano T; Sakai S; Kawaguchi Y; Hosoya T
    Kidney Int Suppl; 1999 Jul; 71():S227-8. PubMed ID: 10412783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of bezafibrate therapy on subfractions of plasma low-density lipoprotein and high-density lipoprotein, and on activities of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in patients with hyperlipoproteinemia.
    Homma Y; Ozawa H; Kobayashi T; Yamaguchi H; Sakane H; Mikami Y; Mikami Y; Nakamura H
    Atherosclerosis; 1994 Apr; 106(2):191-201. PubMed ID: 8060379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
    Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice.
    Berti JA; Amaral ME; Boschero AC; Nunes VS; Harada LM; Castilho LN; Oliveira HC
    Metabolism; 2001 May; 50(5):530-6. PubMed ID: 11319713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of increasing doses of simvastatin on fasting lipoprotein subfractions, and the effect of high-dose simvastatin on postprandial chylomicron remnant clearance in normotriglyceridemic patients with premature coronary sclerosis.
    van Wijk JP; Buirma R; van Tol A; Halkes CJ; De Jaegere PP; Plokker HW; van der Helm YJ; Castro Cabezas M
    Atherosclerosis; 2005 Jan; 178(1):147-55. PubMed ID: 15585212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein changes in children after liver transplantation: mild hypertriglyceridemia and a decrease in HDL3/HDL2 ratio.
    Granot E
    Hepatology; 1998 Jan; 27(1):175-80. PubMed ID: 9425934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein composition in insulin-dependent diabetes mellitus with chronic renal failure: effect of kidney and pancreas transplantation.
    Hughes TA; Gaber AO; Amiri HS; Wang X; Elmer DS; Winsett RP; Hathaway DK; Hughes SM; Ghawji M
    Metabolism; 1994 Mar; 43(3):333-47. PubMed ID: 8139482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Density Lipoprotein and Low-Density Lipoprotein Subfractions in Patients with Chronic Kidney Disease.
    Rysz-Gorzynska M; Gluba-Brzozka A; Banach M
    Curr Vasc Pharmacol; 2017; 15(2):144-151. PubMed ID: 27697068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidized low-density lipoprotein and lipoprotein(a) levels in chronic kidney disease patients under hemodialysis: influence of adiponectin and of a polymorphism in the apolipoprotein(a) gene.
    Ribeiro S; Faria Mdo S; Silva G; Nascimento H; Rocha-Pereira P; Miranda V; Vieira E; Santos R; Mendonça D; Quintanilha A; Costa E; Belo L; Santos-Silva A
    Hemodial Int; 2012 Oct; 16(4):481-90. PubMed ID: 22515595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analyzing of high-density lipoprotein subfractions and low-density lipoprotein subfractions in human serum with anion-exchange chromatography.
    Hirowatari Y; Tsunoda Y; Ogura Y; Homma Y
    Atherosclerosis; 2009 Jun; 204(2):e52-7. PubMed ID: 19091316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Density Lipoprotein Subfractions and Their Oxidized Subfraction Particles in Patients with Chronic Kidney Disease.
    Honda H; Hirano T; Ueda M; Kojima S; Mashiba S; Hayase Y; Michihata T; Shibata T
    J Atheroscler Thromb; 2016; 23(1):81-94. PubMed ID: 26289085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of high plasma triglyceride levels associated with obesity and regional adipose tissue distribution to plasma lipoprotein-lipid composition in premenopausal women.
    Després JP; Moorjani S; Tremblay A; Ferland M; Lupien PJ; Nadeau A; Bouchard C
    Clin Invest Med; 1989 Dec; 12(6):374-80. PubMed ID: 2612090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.